Stoke Therapeutics, Inc. — Form D

Stoke Therapeutics, Inc. of Bedford, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-02. The offering totals $90.0M, of which $90.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
SAMUEL W HALLDirectorNEW YORK, NY
Seth L HarrisonDirector
Edward M KayeDirectorBedford, MA
Adrian R KrainerDirectorBedford, MA
Arthur A LevinDirectorBedford, MA
Arthur W TzianabosDirectorBedford, MA
Charles R AllersonExecutive OfficerBedford, MA
Isabel M AznarezExecutive OfficerBedford, MA
Edward M KayeExecutive OfficerBedford, MA
Adrian R KrainerExecutive OfficerBedford, MA
Gene M LiauExecutive OfficerBedford, MA
Meena R MeenaExecutive OfficerBedford, MA
Huw M NashExecutive OfficerBedford, MA
Barry M TichoExecutive OfficerBedford, MA
Isabel M AznarezPromoterBedford, MA
Adrian R KrainerPromoterBedford, MA
Huw NashExecutive OfficerCold Spring Harbor, NY
Adrian KrainerDirectorCold Spring Harbor, NY
Adrian KrainerExecutive OfficerCold Spring Harbor, NY
Adrian KrainerPromoterCold Spring Harbor, NY
Isabel AznarezDirectorCold Spring Harbor, NY
Isabel AznarezExecutive OfficerCold Spring Harbor, NY
Isabel AznarezPromoterCold Spring Harbor, NY

Other filings by this issuer (1)

FiledFormOfferingSold
2014-11-24D$850K$850K

More